Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. - Wikidata - awgldk - TriplyDB

Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.

Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.

http://www.wikidata.org/entity/Q41845791

about

Techniques for physicochemical characterization of nanomaterials Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye Ocular drug delivery.Positively and negatively charged liposomes as carriers for transdermal delivery of sumatriptan: in vitro characterization.Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach.Study of ocular drug delivery system using drug-loaded liposomes Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.Recent applications of liposomes in ophthalmic drug delivery.Recent patents on ophthalmic nanoformulations and therapeutic implications Ufasomes nano-vesicles-based lyophilized platforms for intranasal delivery of cinnarizine: preparation, optimization, ex-vivo histopathological safety assessment and mucosal confocal imaging.Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye.Ufasomes Mediated Cutaneous Delivery of Dexamethasone: Formulation and Evaluation of Anti-Inflammatory Activity by Carrageenin-Induced Rat Paw Edema Model Eye drop delivery of pigment epithelium-derived factor-34 promotes retinal ganglion cell neuroprotection and axon regeneration.Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug.Recent perspectives in ocular drug delivery.Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder Promising complexes of acetazolamide for topical ocular administration.Recent advances in ocular drug delivery.Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations.Colloidal drug delivery system: amplify the ocular delivery.Liposomes in topical ophthalmic drug delivery: an update.Gelatin-based particulate systems in ocular drug delivery.Ocular drug delivery systems: An overview.Safety and toxicity of nanomaterials for ocular drug delivery applications.PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.Ciprofloxacin as ocular liposomal hydrogel Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery.Preparation and characterization of cefditoren pivoxil-loaded liposomes for controlled in vitro and in vivo drug release.Ocular Dorzolamide Nanoliposomes for Prolonged IOP Reduction: in-vitroand in-vivo Evaluation in Rabbits.Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide.Design and evaluation of liposomal formulation of pilocarpine nitrate.Preparation and evaluation of thermosensitive liposomal hydrogel for enhanced transcorneal permeation of ofloxacin.Dorzolamide Loaded Niosomal Vesicles: Comparison of Passive and Remote Loading Methods.Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent.Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity.Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.Development and characterization of oleic acid vesicles for the topical delivery of fluconazole.Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.Flurbiprofen-loaded stealth liposomes: studies on the development, characterization, pharmacokinetics, and biodistribution.Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route.

P2860

Q27009549-ECA9D451-5E2B-4B47-8B29-7E0C49FE4957 Q28477033-60510F52-6E4E-4A6C-8AB1-04EEC408560F Q30475605-819A4E0F-D238-4A45-A0F2-5E73B13C1B32 Q33529835-0A5B9EAD-12FD-4D26-88E4-F79EA7F2AA91 Q33739032-4F494414-BD79-4F6F-90F0-0CE8A1936F1B Q34448362-E3231693-B57A-4397-9BD9-6A29D597F76A Q34571360-3595B475-4E86-4F25-8D63-FF05E3EFEDF1 Q34734683-F10F87CF-6579-4652-B747-E8B26731733A Q35043004-106A1159-67ED-4401-9B76-85BA28EB93A6 Q35638055-D11F5C15-72FA-4F8E-96D9-A67FCA077AFE Q35679871-ED7B6762-3F1D-4417-AAB7-117B59C014C2 Q35837675-B8F4858B-B376-49A0-AFC9-0B1BA970E654 Q36159673-8A78538E-82AE-4D90-89E2-E6119311AEE5 Q36268597-F163ECE0-8DD9-4611-984A-1286894C34A4 Q37256549-A2ECA443-4904-452D-A2A7-960E06CEA181 Q37290722-C1037F4B-E6E2-4DA4-9E51-6480E3436280 Q37766607-F437F897-A0B5-46DA-A9CE-65E1BA04D188 Q38059884-199B1D11-A171-482D-8C3F-89509F7BC4F3 Q38155210-9CE7CB3B-10E5-48AF-86F2-82006045F10B Q38217270-C5C8FDFE-F63E-40B5-8764-2DF4D96E7F12 Q38239330-2734FA88-5F02-4F94-8CCC-C0D0AB0CD69A Q38310627-2C3492B5-0AB2-48A0-95EA-EA85DF0E969B Q38318837-C15C9529-1E9F-422E-9874-27481D096EBD Q38793489-B4DA2D9A-7179-435C-B90E-0E955EE1AFEA Q38889788-F41BAF88-86EA-476C-AFE3-92903783B661 Q39923976-19679EF8-F025-4DAB-BC92-FF106F78019E Q40809158-63015B87-C235-4300-A4A9-D2B5A812DDCF Q40941237-E4DCE05F-839A-4B81-9C0A-C2B45DF8E8CF Q41837975-35C3CFC8-9EE6-4415-A860-D162BE50AB75 Q41859594-8942F3EB-1984-469F-9A41-BED7D086D055 Q41892697-B8C2EB9E-DBD7-465C-8B3B-226AF5368F8C Q41989063-9C547652-A4AA-4A17-A733-369350F363D1 Q42360534-E312748A-EECB-43BF-B345-D6AF70494DC8 Q42840446-ACFA171A-A904-4C83-A441-54A2BB957E62 Q43090877-3E86AAB2-C53F-4921-8266-B1734F1C9B32 Q43126395-5C0B8D41-FE06-46C6-9F02-8441313026EC Q43126418-424769E4-12CD-4DAF-971F-F6D2EC458E2E Q43234583-C7A0A25E-3D9F-4038-BF7E-4EA7D29C8B7D Q43246889-297A7435-EAA2-41BF-8623-A61ADA9EA082 Q45377441-2D6E2178-D7EC-49B0-BA93-3FF09E495E1D

P2860

Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.

http://www.wikidata.org/entity/Q41845791

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.

@en

type

label

Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.

@en

prefLabel

Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.

@en

P1433

Q41845791-C4032F8F-9062-4EA4-8FAC-77E805D66045

P1476

Q41845791-3F4427F3-4A42-470D-89CB-EC9CE8415E2A

P2093

Q41845791-104E9CDD-2758-49EB-BEEE-46A5290AF789

Q41845791-1D6BAA7F-DCF4-47BA-9BA3-22C434B64725

Q41845791-4CCB1F52-7CA1-42C0-B7F5-AB5AE07C0326

P2888

Q41845791-88F6EC03-7E35-4DFA-A0B2-AFD94A64D1D9

Q41845791-8FC4614A-790C-4257-B71B-C6A1C24ADA43

P304

Q41845791-2EB338AD-E9DB-4B2A-B8A3-60E199A53DD8

P31

Q41845791-55B9E9A8-6249-4D61-A990-55A27F612CE7

Q41845791-596dfa21-0370-40a2-85ea-edd13922c184

P356

Q41845791-A8BBFFDF-008D-44B1-8577-0080642A329C

Q41845791-FE871F0D-B20A-45A8-961D-9F3105D1C2CB

P407

Q41845791-711D982F-E082-4501-B198-6FB949EA6316

P433

Q41845791-4114519C-8C54-4D56-BF35-281E9D9D8DF7

P478

Q41845791-E41D31C7-EA92-425E-B04A-6EA84837ED90

P50

Q41845791-A108B377-C4D5-4949-B466-B2D8BFDC2016

P577

Q41845791-673ECB5B-848C-4C3D-B7B4-4507221E3716

P5875

Q41845791-22ED1E84-60FE-4CDA-9CC4-EFA17A7DED04

P6179

Q41845791-48EC4F83-A8FE-49FE-9066-4E430203C839

Q41845791-AB8D50D2-A3C3-4262-A8FB-349C4231928B

P698

Q41845791-0EA7DF07-EF44-4E8C-8993-865FFE18000A

P932

Q41845791-7E39EC6C-546A-405A-88E8-7C13C3DCDC78

P356

P1433

AAPS PharmSciTech

P1476

Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies

@en

P2093

Ahmed S Guinedi

http://www.w3.org/2001/XMLSchema#string

Nahed D Mortada

http://www.w3.org/2001/XMLSchema#string

Samar Mansour

http://www.w3.org/2001/XMLSchema#string

P2888

P304

1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/PT0801001

http://www.w3.org/2001/XMLSchema#string

10.1208/PT0804080

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Rania M. Hathout

P577

2007-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6414152

http://www.w3.org/2001/XMLSchema#string

P6179

1004954370

http://www.w3.org/2001/XMLSchema#string

1017103453

http://www.w3.org/2001/XMLSchema#string

P698

17408209

http://www.w3.org/2001/XMLSchema#string

P932

2750666

http://www.w3.org/2001/XMLSchema#string